Form 4 holding
Director
Aprea Therapeutics, Inc.
- Security class
- Pre-Funded Warrant
- Shares / value
- 123,915
- Estimated value
- $99,999
- Report date
- 31 Mar 2026
- Price
- $0.8070
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount